In Washington, DC and state capitals around the country, Lupus Foundation of America advocates tell their stories and urge their elected officials to support policies that improve the lives of people ...

Supporting lupus patients and advocates in Arizona.

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one engages with loved ones and the broader community. While lupus is often ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

There are multiple chapters near you. Select your preferred chapter.

The Lupus Foundation of America works with medical experts and people with lupus and their care partners to offer clear, easy-to-use educational materials and toolkits to help you navigate every step ...

A recent survey was conducted by TEAM LEWIS on behalf of the Lupus Foundation of America (LFA) to explore American’s awareness and knowledge of lupus. 1,000 individuals in the US, ages 18 or older, ...

New Lupus Foundation of America survey shines a light on cruel and mysterious disease during Lupus Awareness Month A new survey commissioned by the Lupus Foundation of America (LFA) for Lupus ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...

Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...

Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...